Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4A11 | Q02928 | 4/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | GLS | O94925 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | PPIA | P62937 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15804691 | 1.00 | CYP4A11 (0.39) | CYP4A11CYP4F2TDP1NR1H2PPARA | |
| SCHEMBL2724637 | 0.92 | THRA (0.40) | SPHK1 | |
| SCHEMBL15804692 | 0.91 | GLS (0.34) | PPARAGLSSIGMAR1CA2POLB | |
| SCHEMBL15796719 | 0.84 | CYP4A11 (0.41) | CYP4A11CYP4F2PPARACA2SPHK1 | |
| SCHEMBL3120458 | 0.81 | PPARG (0.42) | SIGMAR1PPIA | |
| SCHEMBL2052924 | 0.80 | PPARA (0.33) | PPARAGLSSPHK1 | |
| SCHEMBL565901 | 0.80 | SPHK1 (0.39) | POLBSPHK1 | |
| SCHEMBL4149000 | 0.79 | THRA (0.36) | PPARA | |
| SCHEMBL4137663 | 0.79 | THRA (0.36) | PPARA | |
| SCHEMBL17733226 | 0.78 | MTNR1B (0.39) | GLSSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8277775-B2 | Boron dipyrromethene difluoro (BODIPY) conjugates | THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2012-10-02 | — | — | US | disclosed |
| US-20110082300-A1 | Boron Dipyrromethene Difluoro (Bodipy) Conjugates | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2011-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110082300-A1 | Boron Dipyrromethene Difluoro (Bodipy) Conjugates | S1PR5, S1PR3, S1PR4 | CYP4A11 2224/4885CYP4F2 632/4885TDP1 1486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.